G1 Therapeutics to Participate in Two August Investor Conferences
Monday August 7, 2023, G1’s Chief Executive Officer Jack Baileyand other members of G1’s Executive Team will participate in the 2023 BTIG Virtual Biotechnology Conference. BTIG-hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative.
Wednesday August 9, 2023, the G1 team will also participate in one-on-one meetings with institutional investors during the 2023 Wedbush PacGrow Healthcare Conferencein New York City. If interested in a meeting, please contact your Wedbush PacGrow representative.
G1 Therapeutics® and the
Vice President, Investor Relations & Corporate Communications
Source: G1 Therapeutics